Evidence map›Paper›PMID 30241226›Full record

ArticleJournal of global oncology2018

Promoting Clinical Breast Evaluations in a Lower Middle-Income Country Setting: An Approach Toward Achieving a Sustainable Breast Health Program.

Roziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, Guldarbogh Sadonshoeva, Saleem Sayani, Aliya Aminmuhammad, Farin Amersi, Sheemain Asaria, Mansoor Saleh and 1 more

Abstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roziya BuribekovaRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Irina ShukurbekovaRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Surayo IlnazarovaRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Nekruz JamshevovRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Guldarbogh SadonshoevaRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Saleem SayaniRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Aliya AminmuhammadRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Farin AmersiRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Sheemain AsariaRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Mansoor SalehRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.
Zohray TalibRoziya Buribekova, Irina Shukurbekova, Surayo Ilnazarova, Nekruz Jamshevov, and Guldarbogh Sadonshoeva, Aga Khan Health Services, Dushanbe, Tajikistan; Saleem Sayani and Aliya Aminmuhammad, Aga Khan University; Farin Amersi, Sheemain Asaria, Mansoor Saleh, and Zohray Talib, Aga Khan Health Board, Karachi, Pakistan; Zohray Talib, George Washington University School of Medicine, Washington, DC; and Mansoor Saleh, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo promote a systems-based approach for the early detection and downstaging of breast cancer at presentation in the remote mountainous region of Gorno Badakhshan Autonomous Oblast (GBAO), Tajikistan, by introducing breast cancer awareness into the community and training health care professionals in clinical breast evaluation (CBE).

methodsThrough a public-private partnership between the Ministry of Health, the Aga Khan Health Services, Tajikistan, and the Aga Khan Health Board, we organized breast cancer screening in the community and trained family medicine doctors (FMDs) and family medicine nurses (FMNs) in CBE. We identified and trained CBE master trainers, who, in turn, systematically trained FMNs to conduct CBEs in each of the remote regional clinics.

resultsBetween 2014 and 2017, 47 FMDs (85% of all FMDs in GBAO), 166 FMNs (55% of all FMNs in GBAO), and six master trainers were trained. Of 3,556 women who were screened, abnormal CBEs were noted in 696 of them (20%). Of the last 1,101 CBEs that were performed by trainee FMNs, with secondary CBEs by master trainers, the rate of abnormal CBEs plateaued at 9%. A total of 18 women were diagnosed with breast cancer-2.6% of abnormal CBEs and 0.5% of all screened women.

conclusionA dual-pronged approach of community awareness and CBE training of health care professionals, supported by CBE master trainers, offers a sustainable approach for the early detection of breast pathology. We observed anecdotal evidence of clinical early-stage detection over time with improved CBE proficiency and community acceptance. Sustaining this program will require advocacy by health care providers and a responsive public policy to support the early detection and treatment of breast cancer across the region.

Indexed as

AdultBreast NeoplasmsEarly Detection of CancerFemaleHumansSocial Class

Identifiers

PMID30241226
PMCPMC6223421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.